Occudo Quantitative Strategies’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,552
Closed -$104K 1456
2022
Q3
$104K Sell
40,552
-102,585
-72% -$327K 0.01% 1036
2022
Q2
$346K Buy
+143,137
New +$376K 0.03% 744
2021
Q1
Sell
-12,415
Closed -$49K 958
2020
Q4
$49K Buy
+12,415
New +$37.5K 0.02% 617

Other funds holding GRTS

Occudo Quantitative Strategies's GRTS Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022, closing a stake of 40,552 shares — an estimated $104K sold.

Occudo Quantitative Strategies first reported a position in GRTS in Q4 2020 and held it in 3 quarters. The position peaked at $346K in Q2 2022. 91 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 40,552 Gritstone bio, Inc. Common Stock shares in Q4 2022, an estimated $104K.
  • Occudo Quantitative Strategies first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Gritstone bio, Inc. Common Stock position peaked at $346K in Q2 2022.
  • 91 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.